Wolfe Research analyst Scott Group downgrades Alaska Air Gr (NYSE:ALK) from Outperform to Peer Perform.
Lexicon To Present Study Results Relating To Sotagliflozin And LX9211 At The 59th Annual Meeting Of The European Association For The Study Of Diabetes
INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failureLX9211 is an investigational, non-opioid treatment for diabetic peripheral neuropathic painTHE WOODLANDS, Texas, Sept. 26, 2023 (GLOBE
